For years, lung cancer has been the leading cause of cancer deaths in non-Hispanic Black women. That changed in 2019 – it’s now breast cancer. And there are racial disparities when it comes to ...

Breast cancer symptoms vary from person to person, and many people don't have any symptoms in the early stages. Some common symptoms include breast lumps, pain, swelling, and changes to the skin.

At MSK, our team of breast cancer experts is here for you. You may be reading this because you or someone you care about learned they have breast cancer. Or maybe you’re curious about your risk of ...

Breast cancer screening can help find cancer early when it’s easier to treat. Screening guidelines are based on your risk (chances) of getting breast cancer. If you’re at average risk, we recommend ...

There's a troubling rise in breast cancer in women under the age of 50, an American Cancer Society report shows, but there are things you can do to help lower your risk. Oct 8, 2024 ...

Researchers say the vaccine, developed by Anixa Biosciences and funded by the Department of Defense, could eliminate breast cancer - which one out of eight women will get in her life - by 2030.

A breast cancer diagnosis is an all-too-common reality for women around the world. In the US, about 240,000 cases of breast cancer are diagnosed in women every year, the US Centers for Disease ...

Learn more about where breast cancer could metastasize, to prepare you for conversations with your doctor laflor/Getty Stock Image When breast cancer spreads to other parts of the body, it’s ...

Breast cancer or BRCA genes are present in every cell of the human body. When functioning, BRCA1 and BRCA2 repair DNA and prevent cancerous changes. However, when a mutation compromises these ...

Hormone-blocking drugs can be life-saving for breast cancer survivors, reducing risk of recurrence by as much as 50%. Yet many patients stop taking them early or don’t take them as directed. A new CU ...

An accompanying editorial, by Dr. Seema Ahsan Khan, a breast cancer surgeon at Northwestern University, and Masha Kocherginsky, a biostatistician also at Northwestern, called it a conundrum.